Investors weighing growth-stage technology names often look for a clean stock comparison between companies that appear similar on the surface yet diverge sharply in business model and market positioning. That contrast is especially pronounced with DOCN and WEAV. Both operate in software and leverage artificial intelligence, but one is a high-momentum cloud infrastructure provider and the other is a healthcare-focused vertical software business whose public-market story has reached a definitive endpoint. This comparison is most relevant for traders evaluating relative performance and momentum, as well as for investors studying how differing growth drivers and corporate events reshape a stock's risk profile. I also checked this using Tickeron’s AI Screener to see how the names line up against peers.
DOCN is DigitalOcean Holdings, Inc., a cloud platform that has repositioned itself around an "AI-native" strategy, offering compute, storage, and inference services tailored to developers and growing technology companies. In recent market activity, the company has reported accelerating growth, with quarterly revenue rising roughly 40% year over year and annual recurring revenue (ARR) climbing past $1.2 billion. AI customer ARR has surged by a triple-digit percentage, reflecting strong adoption of its inference offerings. From what I see, the operational momentum here is notable even as broader sector sentiment adds volatility.
Despite these operational gains, DOCN has exhibited pronounced volatility. The stock remains well below its 52-week high even after posting substantial year-to-date gains, and recent weeks have featured sharp moves driven by broader AI-infrastructure sentiment rather than company-specific news. Factors such as peer earnings, regulatory concerns around data-center expansion, and a new at-the-market equity program have all influenced price behavior. Analysts continue to hold broadly constructive ratings, but the name trades at a demanding valuation relative to near-term earnings.
WEAV is Weave Communications, Inc., a vertical software-as-a-service (SaaS) provider offering an AI-powered patient engagement and payments platform for small and mid-sized healthcare practices, including dental and medical offices. The company serves more than 40,000 customer locations and has grown revenue in the mid-to-high teens on a percentage basis in recent quarters, with improving operating margins and rapid growth in AI interactions and payments revenue.
However, the defining development in WEAV's recent history is corporate rather than operational. In August 2026, the company agreed to be acquired by private equity firm Francisco Partners in an all-cash transaction valued at approximately $650 million, or $7.40 per share—a roughly 34% premium to its unaffected price. The transaction closed in late October 2026, at which point WEAV common stock ceased trading and was delisted from the New York Stock Exchange. As a result, the stock no longer presents a tradable public-market opportunity.
Tickeron maintains a large library of AI trading bots that collectively monitor and trade thousands of different tickers across varying strategies, timeframes, and risk profiles. Because not every bot suits every market environment, Tickeron curates a focused Trending AI Robots section that highlights the strategies currently aligned with prevailing market conditions. These bots differ in trading style, timeframe, performance statistics, and the specific sets of tickers they cover, giving users a way to evaluate diversified approaches side by side. For traders seeking a systematic, data-driven perspective on relative momentum and positioning, reviewing the Trending AI Robots page can offer a useful starting point. I’m watching this closely as market conditions shift.
The clearest contrast between DOCN and WEAV is their current market status. DOCN remains a publicly traded, high-growth cloud platform exposed to the volatile but expanding AI infrastructure theme, with meaningful top-line momentum offset by heavy capital spending and a GAAP net loss. WEAV, by contrast, is a profitable-focused vertical SaaS business whose growth is steadier but slower, and whose public listing has been terminated through a completed take-private transaction.
On growth drivers, DOCN is levered to enterprise AI adoption and rising inference workloads, while WEAV is tied to healthcare practice digitization and payment processing. Risk factors differ accordingly: DOCN faces valuation, capital-intensity, and sentiment risks, whereas WEAV's prior risks—modest net revenue retention and a go-to-market transition—were ultimately resolved through acquisition. From a market sentiment standpoint, DOCN commands attention as a tradable momentum name, while WEAV has effectively exited the public arena.
Based on observable factors such as trend consistency, liquidity, relative momentum, and market positioning, Tickeron's AI would likely favor DOCN in this comparison. DOCN retains an active, tradeable trend with accelerating revenue growth and substantial analyst coverage, whereas WEAV no longer offers a public-market trend to trade following its completed acquisition. This conclusion is probabilistic in nature, reflecting the AI's assessment of current conditions rather than a definitive forecast of future performance. One thing that stands out is how corporate events can quickly alter the tradable landscape.
In my own analysis, I often rely on Tickeron’s AI Trading Bots to test and automate approaches across different timeframes and risk levels. These tools help surface strategies that align with current market conditions, making it easier to compare opportunities like the ones discussed here without relying solely on manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for DOCN moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for DOCN just turned positive on November 12, 2026. Looking at past instances where DOCN's MACD turned positive, the stock continued to rise in 46 of 51 cases over the following month. The odds of a continued upward trend are 90%.
Following a +2.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOCN advanced for three days, in 235 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
DOCN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DOCN as a result. In 64 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The 10-day moving average for DOCN crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.
The 50-day moving average for DOCN moved below the 200-day moving average on November 17, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOCN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for DOCN entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 18 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. DOCN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.156) is normal, around the industry mean (16.188). P/E Ratio (28.648) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (1.538) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (13.947) is also within normal values, averaging (103.301).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOCN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications